Abstract
Dysregulated translation is a common feature of cancer. Uncovering its governing factors and underlying mechanism are important for cancer therapy. Here, we report that enhancer of zeste homologue 2 (EZH2), previously known as a transcription repressor and lysine methyltransferase, can directly interact with fibrillarin (FBL) to exert its role in translational regulation. We demonstrate that EZH2 enhances rRNA 2′-O methylation via its direct interaction with FBL. Mechanistically, EZH2 strengthens the FBL–NOP56 interaction and facilitates the assembly of box C/D small nucleolar ribonucleoprotein. Strikingly, EZH2 deficiency impairs the translation process globally and reduces internal ribosome entry site (IRES)-dependent translation initiation in cancer cells. Our findings reveal a previously unrecognized role of EZH2 in cancer-related translational regulation.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 341-354 |
| Number of pages | 14 |
| Journal | Nature Cell Biology |
| Volume | 23 |
| Issue number | 4 |
| DOIs | |
| State | Published - Apr 2021 |
ASJC Scopus subject areas
- Cell Biology
Fingerprint
Dive into the research topics of 'A PRC2-independent function for EZH2 in regulating rRNA 2′-O methylation and IRES-dependent translation'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS